-
“Elimination of tuberculosis (TB) is more than an aspiration. We know it
could become a reality, but this will happen only if we achieve radical
transformation in the way TB is diagnosed, treated and prevented. This
goal can be realized only if TB research is intensified and envisioned
in an entirely new way.”
02 November 2011 | Tuberculosis Vaccine Initiative (TBVI)
-
Researchers have developed a potential vaccine against tuberculosis that completely eliminates tuberculosis bacteria from infected tissues in some mice. The vaccine was created with a strain of bacteria that, due to the absence of a few genes, are unable to avoid its host's first-line immune response.
31 October 2011 | Science Daily
-
HHMI researchers have developed a potential vaccine against tuberculosis that completely eliminates tuberculosis bacteria from infected tissues in some mice.
04 September 2011 | Eurekalert Inf Dis
-
A new vaccine to combat tuberculosis is less effective at stimulating an immune response when administered to Gambian infants in combination with the routine immunization schedule, according to the results of a clinical trial part-funded by the Wellcome Trust.
22 June 2011 | Eurekalert Inf Dis
-
All newborn children in London could be vaccinated to reduce the spread of tuberculosis (TB), under proposals that are out for consultation.
03 June 2011 | BBC Health
-
In a new article, experts discuss recent advances in vaccine development. New tools including systems biology and structure-based antigen design could lead to a deeper understanding of mechanisms of protection and illuminate the path to rational vaccine development to lift the burden of the world's most devastating infectious diseases.
25 May 2011 | Science Daily
-
A team of researchers is launching the BCG World Atlas: a first-of-its-kind, searchable website that provides detailed information on TB vaccination policies and practices for more than 180 countries.The BCG vaccination can cause false positives in the skin test that's routinely used to screen for latent TB. "As a clinician, if you're trying to interpret the skin test in a foreign-born person, you're going to want to know when the BCG vaccination was given back home and how many times it has been given," the Atlas' project leader said.
22 March 2011 | Eurekalert Medicine & Health
-
Aeras announced it will initiate a Phase I clinical trial of an investigational live recombinant tuberculosis vaccine at Saint Louis University. The new vaccine, called AERAS-422, is a modernized version of the currently used TB vaccine - Bacille Calmette Guerin, which is widely viewed as insufficient in preventing pulmonary TB.
23 September 2010 | Eurekalert Medicine & Health
-
Policymakers and opinion leaders must recognize TB as a growing global
threat and marshal significantly greater resources to support vaccine
research and the ambitious plan to save millions of lives with them.
21 September 2010 | Science Speaks: HIV & TB News
-
Elderly people might not benefit from some of the tuberculosis vaccines currently in development, recent research suggests.
20 September 2010 | Eurekalert Medicine & Health
Talking points: a checklist for you and your doctorTalking points is designed to help you talk to your doctor about HIV
treatment.
Preventing HIVAn essential resource providing evidence-based information on preventing HIV infection. 
HIV treatment update – Winter 201206 February 2012The new edition of HIV treatment update (HTU) is now...
A visit from Wandsworth Oasis26 January 2012On Wednesday this
week, we were delighted to have a visit...
Adventurers with HIV – a photo gallery19 January 2012Back in
November we sent out a
call for adventurous people with...